The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Concerto HealthAI
Leadership - Concerto HealthAI
Stock and Other Ownership Interests - Concerto HealthAI
Travel, Accommodations, Expenses - Concerto HealthAI
Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis.
 
R. Donald Harvey
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Spectrum Pharmaceuticals; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); ArQule (Inst); AstraZeneca (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Five Prime Therapeutics (Inst); Genmab (Inst); Halozyme (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Rgenix (Inst); Sanofi (Inst); Takeda (Inst); Tesaro (Inst); Xencor (Inst)
 
Wendy S. Rubinstein
No Relationships to Disclose
 
Gwynn Ison
No Relationships to Disclose
 
Sean Khozin
No Relationships to Disclose
 
Li Chen
Employment - Concerto HealthAI
Stock and Other Ownership Interests - Concerto HealthAI
 
Robert S. Miller
No Relationships to Disclose
 
Monika Jun
Employment - Celgene; Concerto HealthAI
Stock and Other Ownership Interests - Celgene
 
Edward Stepanski
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen (Inst); AstraZeneca (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Brigham Hyde
No Relationships to Disclose
 
Thomas S. Uldrick
Research Funding - Bayer (Inst); Celgene (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - As an employee of the U.S. Government, I have provisional patent application regarding methods for the treatment of Kaposi’s sarcoma and KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers (Inst)
 
George Anthony Komatsoulis
No Relationships to Disclose
 
Jeremy Roberts
Employment - Concerto HealthAI
 
Elizabeth Garrett-Mayer
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Consulting or Advisory Role - Deciphera; Okava Pharmaceuticals; Tactical Therapeutics; TYME
 
Richard L. Schilsky
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
 
Caroline Schenkel
No Relationships to Disclose
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Genentech/Roche; Ignyta; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Merck; Pfizer; Takeda
 
Suanna S. Bruinooge
No Relationships to Disclose